• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患冠心病的终生风险。

Lifetime risk of developing coronary heart disease.

作者信息

Lloyd-Jones D M, Larson M G, Beiser A, Levy D

机构信息

National Heart, Lung, and Blood Institute's Framingham Heart Study, National Institutes of Health, Massachusetts 01702, USA.

出版信息

Lancet. 1999 Jan 9;353(9147):89-92. doi: 10.1016/S0140-6736(98)10279-9.

DOI:10.1016/S0140-6736(98)10279-9
PMID:10023892
Abstract

BACKGROUND

The lifetime risk of developing coronary heart disease has not been estimated in a general population. We investigated the lifetime risks of initial coronary events at different ages.

METHODS

We assessed data for 7733 participants in the Framingham Heart Study, who had been examined at least once at age 40-94 years between 1971 and 1975, found to be free of coronary heart disease, and then followed up. We estimated the lifetime risks of coronary heart disease (angina pectoris, coronary insufficiency, myocardial infarction, or death from coronary heart disease) by multiple-decrement life-table methods.

FINDINGS

The 7733 patients were followed up for a total of 109,948 person-years. Overall, 1157 participants developed coronary heart disease. 1312 died from non-coronary heart disease causes. Lifetime risk of coronary heart disease at age 40 years was 48.6% (95% CI 45.8-51.3) for men and 31.7% (29.2-34.2) for women. At age 70 years, lifetime risk was 34.9% (31.2-38.7) for men and 24.2% (21.4-27.0) for women. After we excluded isolated angina pectoris as an initial event, the lifetime risk of coronary artery disease events at age 40 years was 42.4% for men and 24.9% for women.

INTERPRETATION

Lifetime risk at age 40 years is one in two for men and one in three for women. Even at age 70 years it is one in three for men and one in four for women. This knowledge may promote efforts in education, screening, and treatment for prevention of coronary heart disease in younger and older patients.

摘要

背景

尚未在普通人群中估计患冠心病的终生风险。我们调查了不同年龄首次发生冠心病事件的终生风险。

方法

我们评估了弗雷明汉心脏研究中7733名参与者的数据,这些参与者在1971年至1975年期间年龄在40 - 94岁之间至少接受过一次检查,当时被发现无冠心病,随后进行随访。我们采用多重递减寿命表法估计冠心病(心绞痛、冠状动脉供血不足、心肌梗死或冠心病死亡)的终生风险。

结果

7733名患者总共随访了109948人年。总体而言,1157名参与者患了冠心病。1312人死于非冠心病原因。40岁时男性患冠心病的终生风险为48.6%(95%可信区间45.8 - 51.3),女性为31.7%(29.2 - 34.2)。70岁时,男性终生风险为34.9%(31.2 - 38.7),女性为24.2%(21.4 - 27.0)。在我们将孤立性心绞痛排除在初始事件之外后,40岁时男性冠心病事件的终生风险为42.4%,女性为24.9%。

解读

40岁时男性终生风险为二分之一,女性为三分之一。即使在70岁时,男性为三分之一,女性为四分之一。这一认识可能会促进针对年轻和老年患者预防冠心病的教育、筛查和治疗工作。

相似文献

1
Lifetime risk of developing coronary heart disease.患冠心病的终生风险。
Lancet. 1999 Jan 9;353(9147):89-92. doi: 10.1016/S0140-6736(98)10279-9.
2
Framingham risk score and prediction of lifetime risk for coronary heart disease.弗雷明汉风险评分与冠心病终生风险预测
Am J Cardiol. 2004 Jul 1;94(1):20-4. doi: 10.1016/j.amjcard.2004.03.023.
3
Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation.冠心病发病后的预后。根据初次冠心病表现对不同性别患者结局差异的调查。
Circulation. 1993 Dec;88(6):2548-55. doi: 10.1161/01.cir.88.6.2548.
4
Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.心血管疾病终生风险和首发表现的性别差异:前瞻性基于人群的队列研究。
BMJ. 2014 Nov 17;349:g5992. doi: 10.1136/bmj.g5992.
5
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.特定年龄时不同胆固醇水平下冠心病的终生风险。
Arch Intern Med. 2003 Sep 8;163(16):1966-72. doi: 10.1001/archinte.163.16.1966.
6
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.根据50岁时的风险因素负担预测心血管疾病的终生风险。
Circulation. 2006 Feb 14;113(6):791-8. doi: 10.1161/CIRCULATIONAHA.105.548206. Epub 2006 Feb 6.
7
Lifetime risk for developing congestive heart failure: the Framingham Heart Study.发生充血性心力衰竭的终生风险:弗雷明汉心脏研究
Circulation. 2002 Dec 10;106(24):3068-72. doi: 10.1161/01.cir.0000039105.49749.6f.
8
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.心房颤动发生的终生风险:弗雷明汉心脏研究
Circulation. 2004 Aug 31;110(9):1042-6. doi: 10.1161/01.CIR.0000140263.20897.42. Epub 2004 Aug 16.
9
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease.弗明汉姆研究中心关于心理社会因素与冠心病的关系。III. 冠心病的八年发病率。
Am J Epidemiol. 1980 Jan;111(1):37-58. doi: 10.1093/oxfordjournals.aje.a112873.
10
Prognosis after initial myocardial infarction: the Framingham study.首次心肌梗死后的预后:弗雷明汉姆研究
Am J Cardiol. 1979 Jul;44(1):53-9. doi: 10.1016/0002-9149(79)90250-9.

引用本文的文献

1
The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles.格列佛综合征:一种解决心血管风险临界患者治疗惰性的概念框架。
Front Cardiovasc Med. 2025 Aug 14;12:1652447. doi: 10.3389/fcvm.2025.1652447. eCollection 2025.
2
Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials.血管内成像引导的经皮冠状动脉介入治疗心血管结局的性别差异:一项随机对照试验的荟萃分析。
JACC Adv. 2025 Aug 18;4(9):102076. doi: 10.1016/j.jacadv.2025.102076.
3
Genetic Risk Score Enables a Vaccine for Early Primary Prevention of CAD.
遗传风险评分助力冠心病早期一级预防疫苗的研发。
Methodist Debakey Cardiovasc J. 2025 Aug 12;21(4):101-112. doi: 10.14797/mdcvj.1617. eCollection 2025.
4
Global, regional, and country-specific lifetime risks of osteoarthritis, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年全球、区域及特定国家骨关节炎的终生风险:全球疾病负担研究2021的系统分析
Glob Health Res Policy. 2025 Jul 22;10(1):29. doi: 10.1186/s41256-025-00419-9.
5
Novel Concepts for the Estimation of Lifetime Cardiovascular Risk.评估终生心血管风险的新观念
High Blood Press Cardiovasc Prev. 2025 Jun 9. doi: 10.1007/s40292-025-00724-x.
6
Incidence of Cardiovascular Events in Hypertensive Patients Based on the Quantity of Major Risk Factors According to the Isfahan Cohort Study.基于伊斯法罕队列研究中主要危险因素数量的高血压患者心血管事件发生率
Int J Hypertens. 2025 May 20;2025:3743691. doi: 10.1155/ijhy/3743691. eCollection 2025.
7
Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022: A population-based study in 185 countries.2022年全球、区域和国家肺癌发病及死亡终生风险:一项基于185个国家人群的研究
Chin Med J (Engl). 2024 Dec 20;137(24):3101-3107. doi: 10.1097/CM9.0000000000003368. Epub 2024 Nov 13.
8
Macrophage Migration Inhibitory Factor Gene Polymorphism in Acute Coronary Syndrome.急性冠状动脉综合征中巨噬细胞移动抑制因子基因多态性
Cureus. 2024 Sep 22;16(9):e69914. doi: 10.7759/cureus.69914. eCollection 2024 Sep.
9
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease.心血管代谢疾病中极低密度脂蛋白产生的分子调控与治疗靶点
Cell Mol Gastroenterol Hepatol. 2025;19(1):101409. doi: 10.1016/j.jcmgh.2024.101409. Epub 2024 Oct 12.
10
Aberrant origin of the left coronary artery from the right coronary sinus with a common orifice with the right coronary artery.左冠状动脉起自右冠状动脉窦且与右冠状动脉有共同开口的异常起源。
Clin Case Rep. 2024 Aug 27;12(9):e9363. doi: 10.1002/ccr3.9363. eCollection 2024 Sep.